Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patency Rate”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07132970
What this trial is testing

Leakage Rate of Ileo-COlic Sutured Anastomosis After Right Hemicolectomy

Who this might be right for
Anastomotic LeakColon CancerRight Hemicolectomy
Aesculap AG 249
Not applicableStudy completedNCT04485936
What this trial is testing

Evaluation of the Effect of Epitomee Device on Gastric Emptying Rate in Healthy Subjects

Who this might be right for
Overweight and Obesity
Epitomee medical 10
Large-scale testing (Phase 3)Study completedNCT01489254
What this trial is testing

Efficacy and Safety of GTR in Comparison to Copaxone®

Who this might be right for
Multiple Sclerosis
Synthon BV 794
Early research (Phase 1)Looking for participantsNCT06232083
What this trial is testing

A Multi Tumor, Open Phase I Clinical Study on the Progression of First-line Anti-tumor Therapy Using Cardonizumab Combined With Pulsed Low-dose Rate External Irradiation (PLDR)

Who this might be right for
Lung CancerEsophageal CancerCervical Cancer
Anhui Provincial Hospital 20
Large-scale testing (Phase 3)Ended earlyNCT03635996
What this trial is testing

Safety Study of Intranasal Etripamil for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia (PSVT). NODE-302

Who this might be right for
Paroxysmal Supraventricular Tachycardia
Milestone Pharmaceuticals Inc. 169
Testing effectiveness (Phase 2)Study completedNCT02083354
What this trial is testing

Study to Investigate the Objective Response Rate of Dabrafenib in Combination With Trametinib in Subjects With BRAF V600 Mutation-Positive Melanoma

Who this might be right for
CancerMelanoma
Novartis Pharmaceuticals 77
Post-approval studies (Phase 4)Study completedNCT02391337
What this trial is testing

Rate Control Therapy Evaluation in Permanent Atrial Fibrillation (RATE-AF)

Who this might be right for
Permanent Atrial Fibrillation
University of Birmingham 161
Not applicableStudy completedNCT00925951
What this trial is testing

The Effectiveness of Wet Cupping on Persistent Non-specific Low Back Pain

Who this might be right for
Low Back Pain
Korea Institute of Oriental Medicine 37
Not applicableUnknownNCT03892577
What this trial is testing

Real-world Study for Patients With Advanced Hepatobiliary Tumors

Who this might be right for
Objective Response RateProgression-free SurvivalOverall Survival+4 more
Peking Union Medical College Hospital 3,000
Not applicableStudy completedNCT02809989
What this trial is testing

Evaluate the Effect of Ovaleap® on the Pregnancy Rate and Clinical Effects as Well as the User-friendliness of the Ovaleap®-Pen.

Who this might be right for
Pregnancy RateOocytes
Teva Pharma GmbH 507
Testing effectiveness (Phase 2)Study completedNCT00748358
What this trial is testing

An Open-label Phase II Study With SUTENT in Patients Suffering From Hormone Refractory Prostate Cancer

Who this might be right for
Prostatic NeoplasmsNeoplasms, Hormone-DependentTumor Markers, Biological+2 more
Assistance Publique - Hôpitaux de Paris 50
Large-scale testing (Phase 3)Active Not RecruitingNCT03887455
What this trial is testing

Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease

Who this might be right for
Early Alzheimer's Disease
Eisai Inc. 1,906
Not applicableStudy completedNCT01958229
What this trial is testing

Efficacy Study of Telbivudine in Chronic Hepatitis B Patients

Who this might be right for
Chronic Hepatitis BRoadmap Concept in Chronic Hepatitis B Treatment24-week PCR Negativity of Telbivudine+2 more
National Taiwan University Hospital 23
Testing effectiveness (Phase 2)Study completedNCT02366195
What this trial is testing

Single-arm Trial to Evaluate the Role of the Immune Response to Talimogene Laherparepvec in Unresected Melanoma

Who this might be right for
Unresected Stage IIIb to IVM1c Melanoma
Amgen 112
Post-approval studies (Phase 4)UnknownNCT05209607
What this trial is testing

Social Media-based Bundle Care of AECOPD Patients.

Who this might be right for
Acute Exacerbation of COPDPulmonary Disease, Chronic ObstructiveCOPD+5 more
Beijing Chao Yang Hospital 648
Testing effectiveness (Phase 2)Active Not RecruitingNCT02586857
What this trial is testing

A Phase 1b/2, Multicenter, Open-label Study of ACP-196 in Subjects With Recurrent Glioblastoma Multiforme (GBM)

Who this might be right for
Glioblastoma Multiforme
Acerta Pharma BV 24
Early research (Phase 1)Study completedNCT00481728
What this trial is testing

Evaluation of the Link Between Bladder Sensation and Changes in Skin Electrical Conductance and Heart Rate.

Who this might be right for
Overactive Bladder
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 28
Early research (Phase 1)Study completedNCT01165736
What this trial is testing

To Calculate the Pharmacokinetics (Concentration of Compound in and Rate of Excretion From the Blood) Following a Very Low Dose of Compound Which Will Not Have Any Pharmacological Activity

Who this might be right for
Healthy
Pfizer 40
Early research (Phase 1)Study completedNCT00174512
What this trial is testing

A Methodological Open Label Cross-Over Controlled Study To Assess The Effect Of Drugs On Ventricular Repolarization and QT Interval At Fixed Heart Rate Under Autonomic Blockade

Who this might be right for
Patients With Pace Makers But no Evidence of Ischemic Heart Disease
Pfizer 36
Large-scale testing (Phase 3)UnknownNCT02584582
What this trial is testing

The Effect of GLP-1 on Postprandial Glucagon Secretion Independent of The Gastric Emptying Rate

Who this might be right for
Type 1 Diabetes
Hvidovre University Hospital 10
Next Page